icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Response-guided therapy leads to complete cure after three weeks of all-oral triple-direct acting antiviral regimens in non-cirrhotic chronic hepatitis C genotype 1b Chinese subjects (SODAPI study)
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
George Lau 1,2, Yves Benhamou 3, Guofeng Chen 2, Jin Li 4, Qing Shao 2, Dong Ji 2, Fan Li 2, Bing Li 2, Jialiang Liu 2, Jinlin Hou 5, Jian Sun 5, Cheng Wang 1,5, Jing Chen 1, Vanessa Wu 1, April Wong 1, Chris L.P. Wong 6, Stella T.Y. Tsang 6, Yudong Wang1, Leda Bassit7, Ruian Ke 8,9, Alan S. Perelson 8, Raymond F. Schinazi 7
 
1 Division of Gastroenterology & Hepatology, Humanity & Health Medical Centre, Hong Kong, Hong Kong SAR, China.
2 Second Liver Cirrhosis Diagnosis and Treatment Center, 302 Hospital, Beijing, 100039, China.
3 Service d'Hepatologie, Hôpital Pitie-Salpêtrière, Paris, France. 4 Institute of Infectious Disease, 302 Hospital, Beijing, 100039, China. 5 State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research,
Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
6 Hong Kong Molecular Pathology Diagnostic Centre, Hong Kong SAR, China. 7 Center for AIDS Research, Department of Pediatrics, Emory University School of Medicine and Veterans Affairs Medical
Center, Atlanta, GA, 30322, USA
8 Theoretical Biology and Biophysics, MS-K710, Los Alamos National Laboratory, Los Alamos, NM 87545, USA
9 Department of Mathematics, North Carolina State University, Raleigh, NC 27695, USA

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif

AASLD12.gif

AASLD13.gif